Drug recall · November 2, 2022
Pyridostigmine Bromide Oral Solution recall
Why: cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC 66689-406-01
- Lots / codes
Lot#: 832400, Exp 08/2023
- Quantity
- 1980 cups
- Company
- VistaPharm, Inc., Largo, FL
- Distribution
- USA Nationwide
- Initiated
- September 30, 2022 · Voluntary: Firm initiated
- Classified
- October 21, 2022
- Reported
- November 2, 2022
- Ended
- April 30, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pyridostigmine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.